• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail

Patent and Exclusivity Search Results from query on Appl No 022205 Product 001 in the OB_Rx list.

Patent Data

Appl No Prod No Patent No Patent
Drug Substance
Drug Product
Patent Use
N022205 001 6197341 Mar 13, 2018 Y U - 1229
N022205 001 7452872 Aug 24, 2026 U - 1229
N022205 001 7625884 Aug 24, 2026 U - 1229
N022205 001 8497256 Jun 23, 2031 U - 1229
N022205 001 9192616 Aug 2, 2026 U - 1229

Exclusivity Data

Appl No Prod No Exclusivity Code Exclusivity Expiration
N022205 001 NDF Feb 3, 2015

Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.

View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page

FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through December 2015
Patent and Generic Drug Product Data Last Updated February 10, 2016